Ba-Ssalamah A - Search Results

1

Downregulation of phosphatidylethanolamine binding protein 1 associates with clinical risk factors in gastrointestinal stromal tumors, but not with activation of the RAF-1-MEK-ETV1 pathway.

Schoppmann SF, Beer A, Nirtl N, Ba-Ssalamah A, Brodowicz T, Streubel B, Birner P. Schoppmann SF, et al. Cancer Lett. 2013 Jul 10;335(1):26-30. doi: 10.1016/j.canlet.2013.01.044. Epub 2013 Jan 31. Cancer Lett. 2013. PMID: 23376254

2

Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally advanced esophagogastric cancer previously untreated with chemotherapy for advanced disease: results of the Central European Cooperative Oncology Group Study ESGAS.1.2.001.

Hejna M, Raderer M, Zacherl J, Ba-Ssalamah A, Püspök A, Schmidinger M, Pluschnig U, Brodowicz T, Zielinski CC. Hejna M, et al. Anticancer Drugs. 2008 Jun;19(5):535-9. doi: 10.1097/CAD.0b013e3282fb178a. Anticancer Drugs. 2008. PMID: 18418220 Clinical Trial.

3

Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results.

Ba-Ssalamah A, Matzek W, Baroud S, Bastati N, Zacherl J, Schoppmann SF, Hejna M, Wrba F, Weber M, Herold CJ, Gore RM. Ba-Ssalamah A, et al. Eur Radiol. 2011 Nov;21(11):2326-35. doi: 10.1007/s00330-011-2187-2. Epub 2011 Jun 28. Eur Radiol. 2011. PMID: 21710266

4

Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of Vienna.

Bojic M, Pluschnig U, Zacherl J, Thallinger CM, Ba-Ssalamah A, Maresch J, Datler P, Schoppmann SF, Hejna M. Bojic M, et al. Anticancer Res. 2011 Jun;31(6):2379-82. Anticancer Res. 2011. PMID: 21737668

5

Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma.

Pluschnig U, Schoppmann SF, Preusser M, Datler P, Asari R, Ba-Ssalamah A, Schwameis K, Birner P, Zacherl J, Hejna M. Pluschnig U, et al. Anticancer Res. 2013 Mar;33(3):1035-9. Anticancer Res. 2013. PMID: 23482778

6

Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria.

Bareck E, Ba-Ssalamah A, Brodowicz T, Eisterer W, Häfner M, Högenauer C, Kastner U, Kühr T, Längle F, Liegl-Atzwanger B, Schoppmann SF, Widmann G, Wrba F, Zacherl J, Ploner F; Austrian representatives of Medical and Surgical Oncology, Pathology, Radiology, Nuclear Medicine, Gastroenterology, and Laboratory Medicine. Bareck E, et al. Wien Med Wochenschr. 2013 Mar;163(5-6):137-52. doi: 10.1007/s10354-013-0187-3. Epub 2013 Mar 19. Wien Med Wochenschr. 2013. PMID: 23508516

7

The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.

Schwameis K, Ba-Ssalamah A, Wrba F, Birner P, Prager G, Hejna M, Schmid R, Asari R, Zacherl J, Schoppmann SF. Schwameis K, et al. Anticancer Res. 2013 May;33(5):2085-91. Anticancer Res. 2013. PMID: 23645759

8

Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tract.

Ilhan-Mutlu A, Preusser M, Schoppmann SF, Asari R, Ba-Ssalamah A, Schwameis K, Pluschnig U, Birner P, Püspök A, Zacherl J, Hejna M. Ilhan-Mutlu A, et al. Anticancer Res. 2013 Aug;33(8):3455-9. Anticancer Res. 2013. PMID: 23898119

9

Surgical treatment of GIST--an institutional experience of a high-volume center.

Schwameis K, Fochtmann A, Schwameis M, Asari R, Schur S, Köstler W, Birner P, Ba-Ssalamah A, Zacherl J, Wrba F, Brodowicz T, Schoppmann SF. Schwameis K, et al. Int J Surg. 2013;11(9):801-6. doi: 10.1016/j.ijsu.2013.08.016. Epub 2013 Aug 30. Int J Surg. 2013. PMID: 23999064 Free article.

10

A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer.

Sahora K, Schindl M, Kuehrer I, Eisenhut A, Werba G, Brostjan C, Telek B, Ba'ssalamah A, Stift J, Schoppmann SF, Gnant M. Sahora K, et al. Anticancer Res. 2014 May;34(5):2377-84. Anticancer Res. 2014. PMID: 24778046 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page